Steady Growth of U.S. Fertility Clinics Industry Halted by Covid-19

fertility clinics industry The $6 billion fertility clinics and infertility services industry in the United States had been booming through 2019, thanks to growing demand from American couples that have delayed childbearing, more widespread acceptance of fertility treatment and usage by gay couples, improved success rates, a strong economy, and significant demand from medical tourists from Europe and China.

That has come to an end, however. This year, domestic demand will suffer due to the recession and Covid-19 shut-downs, coupled with the expected lack of medical tourists from China and Europe. Literally 50% of this industry’s clinics shut down for two months so far in 2020, while the other half operates under new state mitigation restrictions and lesser patient volumes. The industry’s enviable growth record has been broken and is not likely to resume until 2022.

Key Facts About the Fertility Clinics Industry

  • Market forecast: Marketdata analysts estimate that the U.S. infertility services market will fall 18% — from $6.0 billion to $4.8 billion this year. Unlike the Great Recession of 2008, which hardly impacted this business, the Coronavirus and recession will result in a much deeper slump. Marketdata analysts also don’t expect a strong rebound in 2021.

  • Competitive landscape: The market is comprised of about 450 fertility clinics, 100+ sperm donor banks, the egg donors market, fertility drugs, and 1,700 reproductive endocrinologists — all competing for the business. ART / IVF procedures performed by fertility clinics are represent $3.3 billion of the total.

  • Potential customer base: This market is largely untapped, as 75% of potential clients are not using infertility services. Only 15% of U.S. women have used fertility drugs, only 5.5% have tried artificial insemination, and only 1% have used IVF. However, the number of IVF cycles performed has grown from 70,000 in 1997 to an estimated 331,000 in 2019.

  • Impact of Covid-19 shut-downs: It’s safe to assume that the 150 hospital-based fertility clinics were closed for two months beginning in mid-March. An estimated 25% of the remaining 300 private clinics were closed as well, but not all. Some chose to remain open, while others closed. In most states, fertility clinics have been considered “essential” healthcare services, but not all — those in Massachusetts were closed.

  • Decline of medical tourism: Chinese and European patients traveling to the U.S. for treatment have fueled much of the industry’s strong growth since 2014, an estimated 20-25% of the business, but their numbers have dwindled in 2020 and likely into 2021.

Where to Learn More

Newly published in May 2020,  U.S. Fertility Clinics & Infertility Services: An Industry Analysis by Marketdata examines the structure and nature of the industry, patient demographics, industry size and growth, competitor profiles, and more. This study is believed to be one of the few in-depth publicly available business analyses that exists of this market. 

View the report page on to read the full abstract and table of contents.

U.S. Fertility Clinics & Infertility Services: An Industry Analysis

About the Author:  John LaRosa is the President of Marketdata LLC and is the author of 100+ industry and market studies. His research appears in top media outlets including ABC, CNN, Fox, ForbesUSA TodayThe Wall Street JournalThe New York Times, and a variety of trade journals. 

Topics: Healthcare Industry Insights